TruBridge, Inc. (TBRG)

TruBridge's stock price has been significantly impacted by several events over the past six months. The company announced its inability to timely file its 2025 Annual Report due to identified material accounting errors, leading to a sharp decline in the stock price and securities fraud investigations. TruBridge announced its Q4 and full-year 2025 results, which included a basic EPS loss of US$0.27 for Q4 and a trailing twelve-month EPS of US$0.30, indicating earnings volatility. Despite regulatory concerns, TruBridge reported a commercial win with Artesia General Hospital deploying Microsoft Dragon Copilot integrated with TruBridge's EHR and announced an expanded partnership with RevSpring. TruBridge provided guidance for Q2 and full-year 2025, with an upward revision to the full-year adjusted EBITDA range, but withheld formal 2026 guidance. As of April 2, 2026, the share price was $16.24, representing a decline of 36.31% from April 4, 2025, and the stock has underperformed the market in the last year.

Specific demand seasonality for TruBridge, Inc.'s products and services is not explicitly detailed in the provided search results. However, the company's 2026 revenue growth expectations consider the seasonality of some revenue streams and the timing of bookings, suggesting that some of TruBridge's revenue streams may experience seasonal fluctuations. The company's focus on healthcare solutions for community hospitals and clinics might imply a relatively stable underlying demand, but specific product or service lines could still be subject to seasonal patterns.

TruBridge, Inc. is a healthcare technology and solutions company that provides services primarily to community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in the healthcare sector, specifically within the health information services industry. TruBridge's core business revolves around Financial Health (Revenue Cycle Management - RCM) and Patient Care (Electronic Health Records - EHR). The Financial Health segment focuses on optimizing the financial performance of healthcare providers, while the Patient Care segment provides comprehensive acute care EHR solutions and related services. TruBridge was founded in 1979 as Computer Programs and Systems, Inc. (CPSI) and rebranded to TruBridge, Inc. in March 2024.

TruBridge, Inc. primarily serves community hospitals, clinics, and healthcare systems in the United States, but also has an international presence. The company is strategically expanding its global footprint and operational capacity, including integrating offshore capabilities through acquisitions. TruBridge plans to double its global workforce-supported clients to 60% by the end of 2025 through continued investment in its offshore capabilities.

TruBridge's brand reputation in the past year has been affected by both positive developments and significant challenges. The company was honored as one of Modern Healthcare's Best in Business, and strategic partnerships and the integration of Microsoft Dragon Copilot into its EHR solutions have contributed positively. However, the disclosure of material accounting errors and the subsequent delay in filing its 2025 Annual Report have led to securities fraud investigations, raising litigation and regulatory risks and likely eroding investor confidence.

TruBridge, Inc. is a publicly traded company with a mix of institutional, retail, and individual investors. Institutional investors hold a significant stake, with 87 institutional owners and shareholders holding a total of 6,748,063 shares as of April 9, 2026. Individual investors hold approximately 12% ownership. Insiders also own shares in TruBridge, with CEO Christopher Fowler owning 0.9% of the company's shares as of August 1, 2025.